Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Hyperglycemia .
This study was a 8 weeks, randomized, double-blind, placebo-controlled 2×2 cross-over design human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Angelica gigas N. extract | Experimental | capsules(2cap/d, 1,000mg/d) for 8 weeks. |
|
| Placebo | Placebo Comparator | Placebo for 8 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Angelica gigas N. extract | Dietary Supplement | capsules(2cap/d, 1,000mg/d) for 8 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes of blood glucose during OGTT (oral glucose tolerance test) | Changes of fasting and postprandial glucose during OGTT were assessed before and after the intervention. | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Changes of blood insulin during OGTT | Changes of blood insulin during OGTT were assessed before and after the intervention. | 8 weeks |
| Changes of Homeostatic model assessment-insulin resistance |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Weight less than 48 kg or weight decreased by more than 10% within past 3 months
Hypoglycemic agent, Obesity medicine, Lipid lowering agent within past 6 months or Blood sugar, Obesity and Lipid improvement functional foods within past 2 weeks
Treated with corticosteroid within past 4 weeks
Severe cardiovascular disease(Mvocardial infarction, Stroke, etc)
Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, etc)
Rheumatoid arthritis, Autoimmune disease
Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
Allergic or hypersensitive to any of the ingredients in the test products
History of disease that could interfere with the test products or impede their absorption
Under antipsychotic drugs therapy within past 2 months
History of alcohol or substance abuse
Participation in any other clinical trials within past 2 months
Laboratory test by show the following results
Pregnancy or breast feeding
Not Contraception(except: Surgery for female infertility)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinical Trial Center for Functional Foods; Chonbuk National University Hospital | Jeonju | Jeollabuk-do | 560-822 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006943 | Hyperglycemia |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
2×2 cross-over Assignment
Not provided
Not provided
Not provided
| Placebo | Dietary Supplement | Placebo for 8 weeks |
|
Changes of physiological parameter{Homeostatic model assessment-insulin resistance(mg/dl)} were assessed before and after the intervention
| 8 weeks |
| Changes of Homeostatic model assessment-beta-cell | Changes of physiological parameter{Homeostatic model assessment-beta-cell(mg/dl)} were assessed before and after the intervention | 8 weeks |
| Changes of HbA1c | Changes of HbA1c(%) were assessed before and after the intervention | 8 weeks |
| Changes of Adiponectin, Leptin | Changes of Adiponectin and Leptin(ng/ml) were assessed before and after the intervention | 8 weeks |
| Changes of lipid profile | Changes of lipid profile were assessed before and after the intervention | 8 weeks |